Metabolic Disorders and Steatosis in Patients with Chronic Hepatitis C: Metabolic Strategies for Antiviral Treatments

par Enjoji, Munechika, Kohjima, Motoyuki, Kotoh, Kazuhiro, Nakamuta, Makoto
Publié 2012

Effects of fibril- or fixed-collagen on matrix metalloproteinase-1 and tissue inhibitor of matrix metalloproteinase-1 production in the human hepatocyte cell line HLE

par Nakamuta, Makoto, Kotoh, Kazuhiro, Enjoji, Munechika, Nawata, Hajime
Publié dans World J Gastroenterol (2005)

A new treatment strategy for acute liver failure

par Kotoh, Kazuhiro, Kato, Masaki, Kohjima, Motoyuki, Nakamuta, Makoto, Enjoji, Munechika
Publié 2010

Baseline characterization of patients aged 70 years and above with hepatocellular carcinoma

par Nakamuta, Makoto, Morizono, Shusuke, Kohjima, Motoyuki, Kotoh, Kazuhiro, Enjoji, Munechika
Publié dans World J Gastroenterol (2005)

A new parameter using serum lactate dehydrogenase and alanine aminotransferase level is useful for predicting the prognosis of patients at an early stage of acute liver injury: A r...

par Kotoh, Kazuhiro, Enjoji, Munechika, Kato, Masaki, Kohjima, Motoyuki, Nakamuta, Makoto, Takayanagi, Ryoichi
Publié 2008

Nutrition Therapy for Liver Diseases Based on the Status of Nutritional Intake

par Yasutake, Kenichiro, Kohjima, Motoyuki, Nakashima, Manabu, Kotoh, Kazuhiro, Nakamuta, Makoto, Enjoji, Munechika
Publié 2012

Dietary habits and behaviors associated with nonalcoholic fatty liver disease

par Yasutake, Kenichiro, Kohjima, Motoyuki, Kotoh, Kazuhiro, Nakashima, Manabu, Nakamuta, Makoto, Enjoji, Munechika
Publié 2014

Local recurrence is an important prognostic factor of hepatocellular carcinoma

par Arimura, Eiichirou, Kotoh, Kazuhiro, Nakamuta, Makoto, Morizono, Shusuke, Enjoji, Munechika, Nawata, Hajime
Publié dans World J Gastroenterol (2005)

Deteriorated portal flow may cause liver failure in patients with hepatocellular carcinoma being treated with sorafenib

par Yamasaki, Akihiro, Umeno, Narihiro, Harada, Shigeru, Tanaka, Kosuke, Kato, Masaki, Kotoh, Kazuhiro
Publié dans J Gastrointest Oncol (2016)

NIM811, a nonimmunosuppressive cyclosporine analogue, suppresses collagen production and enhances collagenase activity in hepatic stellate cells

par Kohjima, Motoyuki, Enjoji, Munechika, Higuchi, Nobito, Kotoh, Kazuhiro, Kato, Masaki, Takayanagi, Ryoiichi, Nakamuta, Makoto
Publié 2007

Serum albumin is present at higher levels in alcoholic liver cirrhosis as compared to HCV-related cirrhosis

par KOTOH, KAZUHIRO, FUKUSHIMA, MARIE, HORIKAWA, YUKI, YAMASHITA, SHINSAKU, KOHJIMA, MOTOYUKI, NAKAMUTA, MAKOTO, ENJOJI, MUNECHIKA
Publié 2012

High relative fat-free mass is important for maintaining serum albumin levels in patients with compensated liver cirrhosis

par Kotoh, Kazuhiro, Nakamuta, Makoto, Fukushima, Marie, Matsuzaki, Chitose, Enjoji, Munechika, Sakai, Hironori, Nawata, Hajime
Publié dans World J Gastroenterol (2005)

Re-evaluation of antitumor effects of combination chemotherapy with interferon-α and 5-fluorouracil for advanced hepatocellular carcinoma

par Enjoji, Munechika, Morizono, Shusuke, Kotoh, Kazuhiro, Kohjima, Motoyuki, Miyagi, Yuzuru, Yoshimoto, Tsuyoshi, Nakamuta, Makoto
Publié dans World J Gastroenterol (2005)

Scattered and rapid intrahepatic recurrences after radio frequency ablation for hepatocellular carcinoma

par Kotoh, Kazuhiro, Enjoji, Munechika, Arimura, Eiichirou, Morizono, Shusuke, Kohjima, Motoyuki, Sakai, Hironori, Nakamuta, Makoto
Publié dans World J Gastroenterol (2005)

Regorafenib could cause sinusoidal obstruction syndrome

par Takahashi, Motoi, Harada, Shigeru, Suzuki, Hideo, Yamashita, Naoki, Orita, Hiroyuki, Kato, Masaki, Kotoh, Kazuhiro
Publié dans J Gastrointest Oncol (2016)

NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease

par Kotoh Kazuhiro, Kato Masaki, Kohjima Motoyuki, Machida Kazuyuki, Enjoji Munechika, Matsunaga Kazuhisa, Nakashima Manabu, Nakamuta Makoto
Publié 2010-03-01

Comparison of tissue pressure and ablation time between the LeVeen and cool-tip needle methods

par Nakamuta, Makoto, Kohjima, Motoyuki, Morizono, Shusuke, Yoshimoto, Tsuyoshi, Miyagi, Yuzuru, Sakai, Hironori, Enjoji, Munechika, Kotoh, Kazuhiro
Publié 2006

NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease

par Enjoji, Munechika, Machida, Kazuyuki, Kohjima, Motoyuki, Kato, Masaki, Kotoh, Kazuhiro, Matsunaga, Kazuhisa, Nakashima, Manabu, Nakamuta, Makoto
Publié 2010

Acute liver failure caused by drug-induced hypersensitivity syndrome associated with hyperferritinemia

par Miyazaki, Masayuki, Tanaka, Masatake, Ueda, Akihiro, Yoshimoto, Tsuyoshi, Kato, Masaki, Nakamuta, Makoto, Kotoh, Kazuhiro, Takayanagi, Ryoichi
Publié 2011

Lactate dehydrogenase production in hepatocytes is increased at an early stage of acute liver failure

par KOTOH, KAZUHIRO, KATO, MASAKI, KOHJIMA, MOTOYUKI, TANAKA, MASATAKE, MIYAZAKI, MASAYUKI, NAKAMURA, KAZUHIKO, ENJOJI, MUNECHIKA, NAKAMUTA, MAKOTO, TAKAYANAGI, RYOICHI
Publié 2011